...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli
【24h】

In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli

机译:耐多药肺炎克雷伯菌和大肠埃希菌在体内出现替加环素耐药性

获取原文
获取原文并翻译 | 示例
           

摘要

Although resistance to tigecycline has been reported in surveillance studies, very few reports have described the emergence of resistance in vivo. We report two cases of patients with infections due to SHV-12-producing Klebsiella pneumoniae and K. pneumoniae carbapenemase-3 (KPC-3)-producing Escherichia coli, which developed tigecycline resistance in vivo after treatment. The reported limited experience underlines the risk of occurrence of a tigecycline MIC increase under treatment pressure.
机译:尽管在监视研究中已经报告了对替加环素的抗药性,但很少有报道描述了体内抗药性的出现。我们报告了两例因产生SHV-12的肺炎克雷伯菌和肺炎克雷伯菌碳青霉烯酶3(KPC-3)产生的大肠杆菌而感染的患者,这些大肠杆菌在治疗后在体内产生了对替加环素的耐药性。报告的有限经验强调在治疗压力下发生替加环素MIC增加的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号